{"date":"2025-04-07","count":12,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6617-2025-04-07-1745-339orf","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-04-07","time":"17:45:57","subject":"更正本公司背書保證資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-04-07 17:45，「更正本公司背書保證資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2025-04-07-1725-9sjnds","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-04-07","time":"17:25:54","subject":"本公司新藥UA002治療男性勃起功能障礙臨床一期收案完成，即將進入臨床二期(Ph2a) (補充評估指標結果)","clause":"第8款","fact_date":"2025-04-02","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-04-07 17:25，「本公司新藥UA002治療男性勃起功能障礙臨床一期收案完成，即將進入臨床二期(Ph2a) (補充評估指標結果)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-04-07-1720-14wpnd6","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-04-07","time":"17:20:39","subject":"美國對等關稅政策對本公司業務財務無重大影響","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-04-07 17:20，「美國對等關稅政策對本公司業務財務無重大影響」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-04-07-1708-19lj0ln","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-04-07","time":"17:08:19","subject":"更正事實發生日(年度誤植)更正本公司113年度合併財務報告附註附表七、大陸投資資訊及個體財務報告附註附表六、大陸投資資訊部分資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-04-07 17:08，「更正事實發生日(年度誤植)更正本公司113年度合併財務報告附註附表七、大陸投資資訊及個體財務報告附註附表六、大陸投資資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-04-07-1707-100g4c8","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-04-07","time":"17:07:10","subject":"公告本公司獨立董事對審計委員會、董事會討論事項表示反對及保留意見","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-04-07 17:07，「公告本公司獨立董事對審計委員會、董事會討論事項表示反對及保留意見」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2025-04-07-1703-1u7pahz","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2025-04-07","time":"17:03:43","subject":"董事會決議不分派股利","clause":"第31款","fact_date":"2025-04-07","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2025-04-07 17:03，「董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-04-07-1657-1w8ced4","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-04-07","time":"16:57:46","subject":"公告本公司申請原料藥新增品項「Selenious Acid」GMP查核，已獲衛福部許可。","clause":"第44款","fact_date":"2025-04-07","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-04-07 16:57，「公告本公司申請原料藥新增品項「Selenious Acid」GMP查核，已獲衛福部許可。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2025-04-07-1635-r9cisp","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2025-04-07","time":"16:35:25","subject":"公告本公司董事會決議通過以資本公積彌補虧損","clause":"第44款","fact_date":"2025-04-07","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2025-04-07 16:35，「公告本公司董事會決議通過以資本公積彌補虧損」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2025-04-07-1604-1hku5w3","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2025-04-07","time":"16:04:58","subject":"公告本公司董事會通過113年度合併財務報告","clause":"第43款","fact_date":"2025-04-07","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2025-04-07 16:04，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2025-04-07-1509-1v75o42","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2025-04-07","time":"15:09:42","subject":"公告本公司限制員工權利新股收回註銷減資變更登記完成","clause":"第35款","fact_date":"2025-04-07","cite_as":"公開資訊觀測站重大訊息：因華（4172），2025-04-07 15:09，「公告本公司限制員工權利新股收回註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-04-07-1109-17a8zsj","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-04-07","time":"11:09:59","subject":"美國進口關稅調整對本公司業務財務無重大影響","clause":"第53款","fact_date":"2025-04-07","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-04-07 11:09，「美國進口關稅調整對本公司業務財務無重大影響」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-04-07-0940-1fqkmsr","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-04-07","time":"09:40:44","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-04-07 09:40，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}